560 Results for "

Opioid Receptor

" in MedChemExpress (MCE) Product Catalog:
Products (560)

560 Results for "Opioid Receptor" in MCE Product Catalog:

19
19 Publications Verification
Cat. No.: HY-15122
CAS No.: 115-53-7
Purity:  99.94%
Sinomenine, an alkaloid extracted from Sinomenium acutum, is a blocker of the NF-κB activation . Sinomenine also is an activator of μ-opioid receptor .
loading...
    loading...
19
19 Publications Verification
Cat. No.: HY-15122A
CAS No.: 6080-33-7
Purity:  99.89%
Synonyms: Cucoline hydrochloride
Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from Sinomenium acutum, is a blocker of the NF-κB activation . Sinomenine also is an activator of μ-opioid receptor .
loading...
    loading...
19
19 Publications Verification
Cat. No.: HY-N0164
CAS No.: 519-02-8
Synonyms: Matridin-15-one; Vegard; α-Matrine
Matrine (Matridin-15-one) is an alkaloid found in plants from the Sophora genus that can act as a kappa opioid receptor and u-receptor agonist. Matrine has a variety of pharmacological effects, including anti-cancer, anti-oxidative stress, anti-inflammation and anti-apoptosis effects. Matrine is potential in the research of disease like human non-small cell lung cancer, hepatoma, papillary thyroid cancer and acute kidney injury (AKI) .
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-B0193
CAS No.: 19216-56-9
Prazosin is an α-adrenergic receptor antagonist. Prazosin can reduce inflammation, relieve anxiety, alleviate panic, prevent memory decline, and modulate the pain-relieving effects of opioids. Prazosin can be used in the study of hypertension and Alzheimer’s disease .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-P0210
CAS No.: 78123-71-4
Target:  

Opioid Receptor

Research Areas:  

Cancer

DAMGO is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-P0210B
CAS No.: 950492-85-0
Target:  

Opioid Receptor

Research Areas:  

Cancer

DAMGO TFA is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-156131
CAS No.: 53179-11-6
Synonyms: ADL 2-1294
Loperamide (ADL 2-1294) is selective and orally active μ opioid receptor agonist with Ki valuess of 3, 48 and 1156 nM against μ, δ and κ opioid receptor, respectively. Loperamide produces antinociception and antihyperalgesia. Loperamide exhibits peripheral selectivity, enhancing fluid, electrolyte, and glucose absorption, reversing PGE2 (HY-101952)- and Cholera toxin (HY-P1446)-induced intestinal secretion, and reducing intestinal motility. Loperamide can be used for the researches of inflammatory pain and protracted diarrhoea .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B0418A
CAS No.: 34552-83-5
Synonyms: R-18553 hydrochloride
Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist . Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-101718
CAS No.: 1174130-61-0
Purity:  99.87%
Synonyms: CERC-501; LY-2456302
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Aticaprant (CERC-501) is a potent and centrally-penetrant kappa opioid receptor antagonist with a Ki of 0.807 nM.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-17417
CAS No.: 357-08-4
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Naloxone hydrochloride is an orally active opioid receptor antagonist. Naloxone hydrochloride attenuates spinal cord stimulation‑associated anti‑hyperalgesic effects, antagonizes physiologic effects of endogenous opioid peptides linked to central nervous system injury sequelae, functions as a pressor agent to induce modest elevations in mean arterial blood pressure, exerts neuroprotective effects to improve post‑traumatic neurologic motor function, blocks opioid receptor‑mediated amnesic pathways, enhances memory consolidation, reverses Adrenocorticotropic hormone (ACTH) (HY-106373)- and epinephrine‑induced amnesia, and potentiates the memory‑facilitatory effects of ACTH and epinephrine .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-17417A
CAS No.: 465-65-6
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Naloxone hydrochloride is an orally active opioid receptor antagonist. Naloxone hydrochloride attenuates spinal cord stimulation‑associated anti‑hyperalgesic effects, antagonizes physiologic effects of endogenous opioid peptides linked to central nervous system injury sequelae, functions as a pressor agent to induce modest elevations in mean arterial blood pressure, exerts neuroprotective effects to improve post‑traumatic neurologic motor function, blocks opioid receptor‑mediated amnesic pathways, enhances memory consolidation, reverses Adrenocorticotropic hormone (ACTH) (HY-106373)‑ and epinephrine‑induced amnesia, and potentiates the memory‑facilitatory effects of ACTH and epinephrine .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-100903
CAS No.: 113158-34-2
Purity:  98.91%
Synonyms: nor-Binaltorphimine dihydrochloride; nor-BNI dihydrochloride
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Norbinaltorphimine dihydrochloride (nor-Binaltorphimine dihydrochloride; nor-BNI dihydrochloride) is a selective, long-acting competitive antagonist of the κ-opioid receptor. Norbinaltorphimine dihydrochloride blocks κ-opioid receptor-mediated analgesic effects, and inhibits butorphanol-induced changes in κ-opioid receptor binding kinetics, desensitization and down-regulation. Norbinaltorphimine dihydrochloride suppresses specific opioid withdrawal symptoms, precipitates withdrawal behaviors in butorphanol-dependent rats, and serves as a molecular probe for studying κ-opioid receptor-agonist interactions. Norbinaltorphimine dihydrochloride is applicable to research related to neurological disorders such as pain .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-117040
CAS No.: 105618-26-6
Purity:  98.70%
Synonyms: Norbinaltorphimine; NorBNI
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

nor-Binaltorphimine (Norbinaltorphimine; NorBNI) is a selective, long-acting competitive antagonist of the κ-opioid receptor. nor-Binaltorphimine blocks κ-opioid receptor-mediated analgesic effects, and inhibits butorphanol-induced changes in κ-opioid receptor binding kinetics, desensitization and down-regulation. nor-Binaltorphimine suppresses specific opioid withdrawal symptoms, precipitates withdrawal behaviors in butorphanol-dependent rats, and serves as a molecular probe for studying κ-opioid receptor-agonist interactions. nor-Binaltorphimine is applicable to research related to neurological disorders such as pain .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-13274
CAS No.: 244218-51-7
Purity:  98.91%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist, binding to ORL1 receptor with a Ki value of 8.2 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-101386
CAS No.: 1997387-43-5
Purity:  99.46%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P0073
CAS No.: 58569-55-4
Synonyms: Met-Enkephalin; Methionine enkephalin; Metenkefalin
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease Cancer

Tyr-Gly-Gly-Phe-Met-OH regulates human immune function and inhibits tumor growth via binding to the opioid receptor.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1334
CAS No.: 88373-73-3
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

DPDPE, an opioid peptide, is a selective δ-opioid receptor?(DOR) agonist?with anticonvulsant effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1334A
CAS No.: 172888-59-4
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

DPDPE TFA, an opioid peptide, is a selective δ-opioid receptor (DOR) agonist with anticonvulsant effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P1013A
Synonyms: [D-Ala2]-Deltorphin II TFA
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Deltorphin 2 TFA is a selective peptide agonist for the δ opioid receptor .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101302
CAS No.: 122517-78-6
Purity:  99.65%
Research Areas:  

Inflammation/Immunology

Naltriben mesylate is a potent δ2-opioid receptor antagonist and a TRPM7 activator. Naltriben mesylate shows Ki values of 0.013 nM, 19 nM and 152 nM for δ, μ and κ receptors, respectively. Naltriben mesylate enhances glioblastoma cell migration and invasion. Naltriben mesylate can be used in research into neurological diseases and cancer .
loading...
    loading...